Siloxane Block Copolymer Surfactant for Microfluidic Droplet Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Microfluidic devices face challenges in achieving efficient droplet operations and maintaining surface tension within the desired range for biomedical applications, as conventional surfactants can inhibit chemical reactions and have compatibility issues with reagents.
Innovation Solution
The use of siloxane-based block co-polymer surfactants, such as CMS-222, which are soluble in PDMS filler fluids but not in aqueous buffers, to adjust the interfacial tension and maintain a surface tension of 6-12 dynes/cm, ensuring efficient droplet formation and movement without interfering with biological functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional surfactants are used to adjust surface tension, then droplet formation and movement are improved, but chemical reactions are inhibited and compatibility with reagents deteriorates
Solution Approach 1:
The patent changes the chemical composition parameters of the surfactant by using siloxane-based block copolymers with specific molecular structures (containing hydrophilic and hydrophobic segments) instead of conventional surfactants. This parameter change allows the surfactant to achieve the desired surface tension adjustment while maintaining compatibility with biological reagents and not interfering with chemical reactions.
Solution Approach 2:
The patent employs composite material design by creating siloxane-based block copolymers that combine different functional segments (hydrophilic and hydrophobic) within a single molecular structure. This composite approach enables the surfactant to simultaneously interact with both aqueous phases and oil phases while being biocompatible, thus resolving the contradiction between surfactant effectiveness and chemical reaction compatibility.
2Ease of operation
If surfactants are added to maintain surface tension, then droplet operations are enhanced, but compatibility with biomedical reagents deteriorates
Solution Approach 1:
The patent modifies the chemical parameters of the surfactant by selecting siloxane-based block copolymers with specific molecular weights and hydrophilic-lipophilic balances. These parameter changes ensure that the surfactant maintains effective surface tension control for droplet operations while being chemically compatible with a wide range of biomedical reagents, thereby improving adaptability.
Solution Approach 2:
The patent employs siloxane-based block copolymers that can be easily removed or degraded after serving their surfactant function. These surfactants are designed to be transient, allowing them to perform their droplet manipulation function and then be discarded or metabolized without leaving harmful residues, thus maintaining reagent compatibility throughout the experiment.
3Stress or pressure
If conventional surfactants are used, then interfacial tension is adjusted, but adverse effects on biological functions occur
Solution Approach 1:
The patent changes the molecular parameters of the surfactant by using siloxane-based block copolymers with specific structural features (siloxane backbone with hydrophilic side chains). These parameter changes result in a surfactant that effectively adjusts interfacial tension while being biologically inert, thus eliminating adverse effects on biological functions while maintaining the required tension control.
Solution Approach 2:
The patent converts the potential harm of conventional surfactants (biological interference) into a benefit by using siloxane-based block copolymers that are specifically designed to be biocompatible. The surfactant's ability to adjust interfacial tension is maintained, but the harmful biological effects are transformed into beneficial neutrality, allowing the surfactant to function without interfering with biological processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The siloxane-based block co-polymer surfactants enhance droplet operations by maintaining the target surface tension, improving droplet formation and movement within microfluidic devices, while being compatible with biomedical applications and avoiding adverse effects on chemical reactions.
Implementation Method 1
The use of siloxane-based block co-polymer surfactants, such as CMS-222, which are soluble in PDMS filler fluids but not in aqueous buffers, to adjust the interfacial tension and maintain a surface tension of 6-12 dynes/cm
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
Disclosed herein are compositions and fluidic devices that include a filler fluid having a siloxane block co-polymer solubilized in the filler fluid. Also disclosed herein are related kits and methods for using the fluidic devices for various uses, such as the polymerase chain reaction or preparations for sequencing reactions.